Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 28, 2008; 14(32): 5020-5024
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5020
Figure 3
Figure 3 The overall abdominal symptom score at baseline in patients with more than minimal symptoms (VAS < 3 cm), compared with scores at week 6 of treatment, with and without ERBHAL at the conclusion of the treatment. A: Without ERBHAL; B: With continuing ERBHAL. Shading indicates the minimal symptom score category. These changes were statistically not significant.